Washington Examiner
Sign in Subscribe
News
Politics
White House
Senate
House
Campaigns
Business
World
Investigations
Justice
Supreme Court
Crime
Entertainment
Washington Secrets
Policy
Defense
National Security
Energy and Environment
Education
Immigration
Finance and Economy
Healthcare
Foreign Policy
Tech
Infrastructure
Space
2026 Election
America at 250
IN FOCUS
Commentary
Columnists
Editorials
Think Tanks
Beltway Confidential
Op-Eds
Restoring America
Patriotism and Unity
Faith, Freedom, and Self-Reliance
Courage, Strength, and Optimism
Equality, Not Elitism
Community and Family
Fairness and Justice
Mission
Watch
Magazine
Magazine
Quarterly Briefing
Archives
Games
Sponsored
Protecting Air Ambulance Services
Powering Progress
ASAE – Association Leadership
National Parks
Examining Tax Reform
Fix TSCA
Inside the Corn Belt
Examining Transportation
Newsletters
Sign In Sign InHome
News
Politics
Policy2026 Election
Opinion
EditorialsOp-Eds
In FocusRestoring AmericaMagazineWatch
Sponsored
Protecting Air Ambulance ServicesPowering ProgressASAE – Association LeadershipNational ParksExamining Tax ReformFix TSCAInside the Corn BeltExamining Transportation
TWS Archive
Advertisement
Home › Authors › Posts by Tom Murphy

Tom Murphy

Read the latest stories and analysis from Tom Murphy.

FILE - This April 20, 2010, file photo shows an exterior view of Amgen offices in Fremont, Calif. Amgen Inc. agreed on Tuesday, Dec. 18, 2012, to pay $762 million to resolve federal litigation accusing the drugmaker of marketing the anemia treatment Aranesp for unapproved uses. (AP Photo/Paul Sakuma, File) Business

Amgen to pay $762M settlement over drug marketing

Tom Murphy · December 18, 2012 10:46 pm
Business

Insurer Centene cuts 2012 forecast again

Tom Murphy · December 14, 2012 6:08 pm
Business

Lilly plans another study for Alzheimer’s drug

Tom Murphy · December 12, 2012 9:40 pm
Business

Key Walgreen revenue metric sinks 6.2 pct in Nov

Tom Murphy · December 5, 2012 7:31 pm
In this Wednesday, Oct. 17, 2012, photo. people pass the Walgreens store in New York's Times Square. Walgreens wants to reward customers for merely taking a walk, and Rite Aid will help cover trial gym memberships for some of its frequent shoppers. All the national drugstore chains now offer a free customer loyalty program loaded with incentives to use their cards. Walgreen Co., the nation's largest drugstore chain, became the latest when it unveiled its Balance Rewards program in September 2012. (AP Photo/Richard Drew) Business

4 questions to ask about drugstore loyalty cards

Tom Murphy · December 5, 2012 7:03 pm
Business

UnitedHealth forecasts 2013 earnings growth

Tom Murphy · November 26, 2012 7:29 pm
Business

HHS details overhaul rules and required benefits

Tom Murphy · November 20, 2012 8:34 pm
Business

Walgreen CEO compensation slips in fiscal 2012

Tom Murphy · November 19, 2012 5:51 pm
Business

5 questions to ask about Medicare Advantage plans

Tom Murphy · November 7, 2012 5:14 pm
Business

Eli Lilly 3Q profit climbs 7 pct, revenue slides

Tom Murphy · October 24, 2012 12:46 pm
Business

Insurer Centene’s 3Q profit plunges 87 percent

Tom Murphy · October 23, 2012 5:55 pm
Business

UnitedHealth plans overseas growth with $4.9B deal

Tom Murphy · October 8, 2012 4:21 pm
Advertisement
  • ‹Previous page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • ›Next page
Page 9 of 11
Advertisement
Washington Examiner Manage Preferences

News

  • Politics
    • White House
    • Senate
    • House
    • Campaigns
  • Business
  • World
  • Investigations
  • Justice
  • Supreme Court
  • Crime
  • Washington Secrets
  • Entertainment
  • Sports

Policy

  • Defense
  • National Security
  • Energy
  • Immigration
  • Finance and Economy
  • Healthcare
  • Foreign Policy
  • Tech
  • Infrastructure
  • Space

Commentary

  • Columnists
  • Editorials
  • Think Tanks
  • Beltway Confidential
  • Op-Eds

Restoring America

  • Patriotism & Unity
  • Faith, Freedom & Self-Reliance
  • Courage, Strength & Optimism
  • Equality, Not Elitism
  • Community & Family
  • Fairness & Justice
  • Mission

Watch

  • Shows
NEWSLETTERS MAGAZINE ARCHIVE
  • Policies and Standards
  • Terms Of Service
  • Subscription Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Transparency In Coverage
  • Advertise
  • Subscribe
  • Contact
  • Careers
  • Staff
  • About Examiner
  • Facebook
  • Twitter
© Copyright 2026. Washington Examiner. All Rights Reserved.
Advertisement